Clonality of Parathyroid Tumors in Familial Multiple Endocrine Neoplasia Type 1
- 27 July 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 321 (4), 213-218
- https://doi.org/10.1056/nejm198907273210402
Abstract
Familial multiple endocrine neoplasia type 1 (MEN-1) is characterized by tumors of the parathyroids, endocrine pancreas, and anterior pituitary. Since the gene associated with MEN-1, located on chromosome 11 (11q13), may normally inhibit tumor proliferation, tumors could arise from inactivation of one or both of the alleles. However, parathyroid tumors in patients with MEN-1 have been considered to result from polyclonal hyperplasia. Using genetic probes, we tested parathyroid tumors for a monoclonal component, represented by a loss of alleles at any of eight loci along chromosome 11.Keywords
This publication has 27 references indexed in Scilit:
- Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11Genomics, 1989
- Genetic Defects in Primary HyperparathyroidismNew England Journal of Medicine, 1988
- Monoclonality and Abnormal Parathyroid Hormone Genes in Parathyroid AdenomasNew England Journal of Medicine, 1988
- Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinomaNature, 1988
- The Approaching Era of the Tumor Suppressor GenesScience, 1987
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcomaNature, 1986
- Surgical management of primary hyperparathyroidismCurrent Problems in Surgery, 1985
- Multicellular Origin of Parathyroid “Adenomas”New England Journal of Medicine, 1977
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971
- The Differential Diagnosis of Parathyroid Adenoma and Chief Cell HyperplasiaAmerican Journal of Clinical Pathology, 1968